METOPROLOL TARTRATE

This brand name is authorized in Nigeria.

Active ingredients

The drug METOPROLOL TARTRATE contains one active pharmaceutical ingredient (API):

1	Metoprolol UNII W5S57Y3A5L - METOPROLOL TARTRATE
	Metoprolol is a cardioselective beta-adrenergic blocking agent. It has a relatively greater blocking effect on beta1-receptors (ie those mediating adrenergic stimulation of heart rate and contractility and release of free fatty acids from fat stores) than on beta2-receptors, which are chiefly involved in broncho and vasodilation.
	Read more about Metoprolol

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-1616	Tablet	Metoprolol 50 mg Tablets TAB 50 mg 2 x 14's (in PVC-Alu blisters)	Film Coated Tablet, Extended Release White colored round shaped biconvex film-coated tablet plain on both sides	25/02/2021

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
METOPROLOL TARTRATE Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C07AB02	Metoprolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-1616